Clinical Trial

The ECMOCYP (cytochromes P450 Activity) Study

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated October 28, 2024 (before its estimated July 2026 completion). Its status may not reflect the trial's current state.
Summary
Prospective open label observational study including patients requiring a tMCS (VA-ECMO or Impella® CP) or in in cardiogenic shock according to the SCAI (Society for Cardiovascular Angiography and Interventions) ESC (European Society of Cardiology) definition 41,42 and not requiring or not eligible to tMCS (ECMO, Impella®, intra-aortic balloon pump) (control group).
Trial Details
NCT Number NCT06662084
Lead Sponsor University Hospital, Geneva
Collaborators: Jean Terrier, Benjamin Assouline, Raphël Giraud, Karim Bendjelid, Caroline Samer, Youssef Daali, Anastasia Zaslavskaya
Conditions ECMO, Cardiogenic Shock, Temporary Mechanical Circulatory Support
Enrollment 46 participants
Start Date 2024-10
Primary Completion 2026-07 (estimated)
Study Completion 2026-07 (estimated)
Updated on ClinicalTrials.gov 2024-10-28